
51 - 200 employees
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $400M Post-IPO Equity on 2026-09
Biotechnology • Pharmaceuticals
Tyra Biosciences is a clinical-stage biotechnology company developing precision medicines. It is advancing clinical studies of oral dabogratinib for skeletal dysplasia and urologic cancers.
🔥 2 minutes ago
🇺🇸 United States – Remote
💵 $405.7k - $442.6k / year
⏰ Full Time
🟠 Senior
🔴 Lead
👔 Vice President
👻 Ghost score 0%
Where this job comes from
Posted on Tyra Biosciences's careers page ↗, not through a job board
First seen by Remote Rocketship 2 minutes ago

51 - 200 employees
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $400M Post-IPO Equity on 2026-09
Biotechnology • Pharmaceuticals
Tyra Biosciences is a clinical-stage biotechnology company developing precision medicines. It is advancing clinical studies of oral dabogratinib for skeletal dysplasia and urologic cancers.
• Develop and execute comprehensive medical affairs strategies aligned with corporate and commercial objectives • Serve as the primary medical affairs leader overseeing scientific communications, medical education, KOL engagement, real-world evidence generation, and medical insights • Partner with R&D and Clinical Development teams to provide medical expertise on pipeline assets and shape evidence generation plans • Build and maintain relationships with Key Opinion Leaders, healthcare professionals, and payers • Represent the company at scientific congresses, advisory boards, and industry forums • Provide scientific and medical leadership for investigator-initiated studies, post-marketing studies, and collaborative research initiatives • Oversee medical education programs, advisory boards, and scientific symposia • Lead publication planning and execution across key medical journals and conferences • Guide medical and commercial materials for scientific accuracy and regulatory compliance • Align Medical Affairs, Commercial, Market Access, and R&D teams on product positioning and medical differentiation • Partner with regulatory and legal teams to ensure compliance with FDA, EMA, and other global regulatory requirements • Provide leadership on value demonstration and payer engagement initiatives • Contribute or lead process improvement initiatives • Perform other duties as assigned
• MD, PharmD, or PhD with extensive experience in Medical Affairs and Oncology • 8 - 10+ years of experience in the pharmaceutical, biotechnology, or life sciences industry, with a strong background in global or US Medical Affairs • Experience in genitourinary cancer, depth in bladder cancer a significant plus • Proven track record of leading medical strategies and teams in a complex, matrixed environment • Strong understanding of clinical development, regulatory landscapes, and payer expectations in the US and/or major international markets • Experience in launch planning, scientific engagement, and evidence generation in a highly competitive therapeutic area • Deep expertise in medical communications, scientific publications, and external stakeholder engagement • Excellent leadership skills with the ability to influence cross-functional teams and drive execution • Direct contributions to high-impact publications, and product launches • Experience with the design and conduct of clinical trials and clinical operations • Excellent communication skills, including ability to create new materials to be used for both internal and external audiences • Demonstrated customer focus and orientation • Evident ability to lead, create, innovate, and flex within a changing environment • Demonstrated ability to respond and move projects forward with a sense of urgency, understanding the need for immediate communication and resolution • Innovative thinking and problem-solving skills, with strong analytical and strategic ability • Excellent written and verbal communication skills • Passion for working in a small, start-up biotech work environment– including being self-motivated and proactive • Ability to accommodate up to 20-30% travel or as business dictates • Are you legally authorized to work in the United States?
• Competitive base, bonus, new hire and ongoing equity packages • Employer-paid Medical, dental, and vision insurance • Employer-paid life insurance, AD&D, short-term disability, long-term disability, and EAP coverage • 401(k) Plan with a fully vested company match 1:1 up to 4% of contributions • Employee Stock Purchase Plan • 14 -18 paid holidays, including office closure between December 25th and January 1st • Flexible vacation • Sick time • Fitness Program • Get Outdoors Program • Paid parental leave benefit • Tuition assistance
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
🔥 5 minutes ago
Regional Vice President leading Daylight Security’s West-region enterprise sales team. Driving cybersecurity revenue through hiring, coaching, forecasting, and strategic deal execution.
🇺🇸 United States – Remote
🔥 Funding within the last year
💰 $80M Early Stage VC (Series B) on 2026-11
⏰ Full Time
🔴 Lead
👔 Vice President
🔥 10 minutes ago
Revolution Medicines VP of Tax leading global tax strategy, reporting, compliance, and audits. Supporting international expansion for innovative RAS-targeted oncology medicines.
🇺🇸 United States – Remote
💵 $294k - $367k / year
🔥 Funding within the last year
💰 $500M POST IPO EQUITY on 2026-04
⏰ Full Time
🔴 Lead
👔 Vice President
🔥 10 minutes ago
Vice President leading global commercial capabilities for Revolution Medicines, an oncology medicine developer. Driving launches, marketing excellence, AI adoption, omnichannel engagement and cross-market collaboration.
🇺🇸 United States – Remote
💵 $294k - $367k / year
🔥 Funding within the last year
💰 $500M POST IPO EQUITY on 2026-04
⏰ Full Time
🔴 Lead
👔 Vice President
🔥 10 minutes ago
Vice President leading analytics, AI, engagement, congress and launch capabilities for Revolution Medicines’ global oncology Medical Affairs organization. Building scalable teams, systems and measurement frameworks for RAS-targeted cancer medicines.
🇺🇸 United States – Remote
💵 $294k - $367k / year
🔥 Funding within the last year
💰 $500M POST IPO EQUITY on 2026-04
⏰ Full Time
🔴 Lead
👔 Vice President
🔥 30 minutes ago
Vice President leading asset analytics and asset-liability management for Symetra, a national financial services company. Directing insurance investment modeling, capital planning, analytics modernization, and quantitative teams.